DiaMedica Therapeutics (DMAC) Other financing activities (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Other financing activities of $420000.0 for Q1 2026, up 346.81% year-over-year from $94000.0 in Q1 2025, and up 51.08% quarter-over-quarter from $278000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Other financing activities (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Other financing activities history runs 6 years deep, the most recent figure standing at $420000.0 for Q1 2026.
- In Q1 2026, Other financing activities rose 346.81% year-over-year to $420000.0; the TTM figure through Mar 2026 stood at $1.3 million (up 278.86% YoY), while the FY2025 annual figure was $1.0 million, up 290.62% from the prior year.
- Other financing activities for Q1 2026 stood at $420000.0, up from $278000.0 in the prior quarter.
- The five-year high for Other financing activities was $465000.0 in Q3 2025, with the low at $7000.0 in Q2 2024.
- The 3-year median for Other financing activities is $144500.0 (2024), against an average of $209500.0.
- Peak annual rise in Other financing activities reached 2228.57% in 2025, while the deepest fall reached 126.02% in 2025.
- DiaMedica Therapeutics' Other financing activities stood at $123000.0 in 2024, then jumped by 126.02% to $278000.0 in 2025, then jumped by 51.08% to $420000.0 in 2026.
- Business Quant data shows DMAC's Other financing activities at $420000.0 in Q1 2026, $278000.0 in Q4 2025, and $465000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 135,000.00 |
| Jun 30, 2026 | 135,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Mar 31, 2026 | 420,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2021 | 244,000.00 |
| Mar 31, 2021 | 244,000.00 |